GreenLight Biosciences’ $102 Million Series D Funding Round

Foley Hoag LLP represented GreenLight Biosciences. GreenLight Biosciences, a Boston, Massachusetts-based RNA vaccine and drug developer, closed its $102 million Series D funding round led by…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Ambrogio Visconti

This content is for Standard 1 Year members only.
Login Join Now